DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,112 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $84,450 | -14.4% | 338 | -14.4% | 0.01% | -12.5% |
| Q1 2024 | $98,640 | +23.6% | 395 | +14.5% | 0.01% | +14.3% |
| Q4 2023 | $79,813 | +13.7% | 345 | +21.9% | 0.01% | 0.0% |
| Q3 2023 | $70,213 | +3.4% | 283 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $67,920 | -35.5% | 283 | -32.3% | 0.01% | -40.0% |
| Q1 2023 | $105,353 | -6.6% | 418 | -1.6% | 0.01% | -9.1% |
| Q4 2022 | $112,804 | -6.0% | 425 | -8.4% | 0.01% | -15.4% |
| Q3 2022 | $120,000 | +34.8% | 464 | +32.6% | 0.01% | +44.4% |
| Q2 2022 | $89,000 | +74.5% | 350 | +101.1% | 0.01% | +80.0% |
| Q1 2022 | $51,000 | +4.1% | 174 | +16.0% | 0.01% | 0.0% |
| Q4 2021 | $49,000 | +40.0% | 150 | +30.4% | 0.01% | +25.0% |
| Q3 2021 | $35,000 | +75.0% | 115 | +53.3% | 0.00% | +33.3% |
| Q2 2021 | $20,000 | +17.6% | 75 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | 0.0% | 75 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $17,000 | +1600.0% | 75 | +971.4% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 7 | -91.6% | 0.00% | -100.0% |
| Q1 2018 | $8,000 | 0.0% | 83 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | +166.7% | 83 | +144.1% | 0.00% | +100.0% |
| Q2 2017 | $3,000 | 0.0% | 34 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | 0.0% | 34 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | 0.0% | 34 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $3,000 | 0.0% | 34 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $3,000 | -25.0% | 34 | -22.7% | 0.00% | 0.0% |
| Q1 2016 | $4,000 | +33.3% | 44 | +29.4% | 0.00% | 0.0% |
| Q4 2015 | $3,000 | 0.0% | 34 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $3,000 | -84.2% | 34 | -84.8% | 0.00% | -90.0% |
| Q2 2015 | $19,000 | -5.0% | 224 | -2.6% | 0.01% | +11.1% |
| Q1 2015 | $20,000 | 0.0% | 230 | 0.0% | 0.01% | +200.0% |
| Q4 2014 | $20,000 | +17.6% | 230 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $17,000 | -5.6% | 230 | +1.3% | 0.00% | 0.0% |
| Q2 2014 | $18,000 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |